WO2005011620A3 - Methods and apparatus for creating particle derivatives of hdl with reduced lipid content - Google Patents
Methods and apparatus for creating particle derivatives of hdl with reduced lipid content Download PDFInfo
- Publication number
- WO2005011620A3 WO2005011620A3 PCT/US2004/006988 US2004006988W WO2005011620A3 WO 2005011620 A3 WO2005011620 A3 WO 2005011620A3 US 2004006988 W US2004006988 W US 2004006988W WO 2005011620 A3 WO2005011620 A3 WO 2005011620A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- hdl
- cholesterol
- methods
- derivatives
- lipid content
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
- A61K9/1275—Lipoproteins; Chylomicrons; Artificial HDL, LDL, VLDL, protein-free species thereof; Precursors thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04718501.2A EP1641421B1 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
ES04718501T ES2715496T3 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for creating derivatives of HDL particles with a reduced lipid content |
DK04718501.2T DK1641421T3 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for producing HDL particle derivatives of reduced lipid content |
JP2006518606A JP2007527387A (en) | 2003-07-03 | 2004-03-08 | Method and apparatus for producing particle derivatives of HDL with reduced lipid content |
AU2004260632A AU2004260632A1 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
CA002531227A CA2531227A1 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48469003P | 2003-07-03 | 2003-07-03 | |
US60/484,690 | 2003-07-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005011620A2 WO2005011620A2 (en) | 2005-02-10 |
WO2005011620A3 true WO2005011620A3 (en) | 2006-05-18 |
Family
ID=34115319
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/006988 WO2005011620A2 (en) | 2003-07-03 | 2004-03-08 | Methods and apparatus for creating particle derivatives of hdl with reduced lipid content |
Country Status (9)
Country | Link |
---|---|
US (5) | US7375191B2 (en) |
EP (2) | EP1641421B1 (en) |
JP (1) | JP2007527387A (en) |
AU (1) | AU2004260632A1 (en) |
CA (1) | CA2531227A1 (en) |
DK (2) | DK2368565T3 (en) |
ES (2) | ES2715496T3 (en) |
PT (2) | PT2368565E (en) |
WO (1) | WO2005011620A2 (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7393826B2 (en) * | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
PT2368565E (en) * | 2003-07-03 | 2015-10-19 | Hdl Therapeutics Inc | Enrichment of pre-beta high density lipoproteins |
EP1685852A1 (en) * | 2005-02-01 | 2006-08-02 | Fondation pour la Recherche Diagnostique | Set of disposable bags for viral inactivation of biological fluids |
PT1917029E (en) * | 2005-07-27 | 2013-03-13 | Lilly Co Eli | A method of treating cancer cells to create a modified cancer cell that provokes an immunogenic response |
US20090038701A1 (en) | 2006-01-17 | 2009-02-12 | Baxter International Inc. | Device, system and method for mixing |
ITMO20060097A1 (en) * | 2006-03-24 | 2007-09-25 | Giuseppe Zucca | DEVICE AND METHOD FOR DILUTION AND PREPARATION OF ANTIBLASTIC DRUGS |
US8785382B2 (en) * | 2006-04-03 | 2014-07-22 | Abbott Cardiovascular Systems Inc. | Lipid therapy |
AU2007200908B2 (en) * | 2007-03-01 | 2012-08-16 | Csl Limited | Treatment of endothelial dysfunction in diabetic patients |
US7956035B2 (en) * | 2007-03-01 | 2011-06-07 | Csl Limited | Treatment of endothelial dysfunction in diabetic patients |
WO2011046504A1 (en) * | 2009-10-18 | 2011-04-21 | Glycorex Ab | Method and product for blood treatment and purification |
US9494605B2 (en) * | 2009-11-20 | 2016-11-15 | Pharnext | Diagnostic tools for charcot-marie-tooth disease |
EP3466969A1 (en) | 2011-02-07 | 2019-04-10 | Cerenis Therapeutics Holding SA | Lipoprotein complexes and manufacturing and use thereof |
US10624924B2 (en) * | 2012-03-12 | 2020-04-21 | Grifols, S.A. | Method and device for treating blood cholesterol disorders |
JP2017515893A (en) | 2014-05-02 | 2017-06-15 | セレニス セラピューティクス ホールディング エスアー | HDL treatment marker |
AU2015201496B2 (en) | 2014-06-03 | 2019-10-31 | Grifols Worldwide Operations Limited | Use of plasmapheresis to treat blood pressure disorders |
US20190021674A1 (en) * | 2017-01-23 | 2019-01-24 | Hdl Therapeutics, Inc. | Methods for Treating Cholesterol-Related Diseases |
EP3589272A4 (en) * | 2017-03-01 | 2020-11-25 | HDL Therapeutics, Inc. | Methods for prophylactically preventing, slowing the progression of, or treating alzheimer's disease |
CA3083194A1 (en) | 2017-11-22 | 2019-05-31 | Hdl Therapeutics, Inc. | Systems and methods for priming fluid circuits of a plasma processing system |
CA3087207A1 (en) | 2017-12-28 | 2019-07-04 | Hdl Therapeutics, Inc. | Methods for preserving and administering pre-beta high density lipoprotein extracted from human plasma |
JP2021523182A (en) * | 2018-05-11 | 2021-09-02 | エイチディーエル セラピューティクス インコーポレイテッドHdl Therapeutics, Inc. | Methods for Preventing, Delaying, or Treating Cerebral Amyloid Angiopathy, Alzheimer's Disease and / or Acute Stroke |
Family Cites Families (148)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3647624A (en) * | 1969-07-24 | 1972-03-07 | Wisconsin Alumni Res Found | Treatment of blood with oleaginous substance |
US3989466A (en) | 1973-08-13 | 1976-11-02 | Pan Samuel C | Liquid-liquid extraction apparatus including fibrous strand packing |
JPS5328989B2 (en) * | 1974-05-27 | 1978-08-17 | ||
US3983028A (en) * | 1974-07-01 | 1976-09-28 | Standard Oil Company (Indiana) | Process for recovering upgraded products from coal |
US3958939A (en) * | 1975-01-08 | 1976-05-25 | Coulter Electronics, Inc. | Method for clarification of lipemic serum |
DE2501376A1 (en) * | 1975-01-15 | 1976-07-22 | Metallgesellschaft Ag | METHOD FOR REMOVING MONOPHENOLS, DIPHENOLS AND THE LIKE FROM WASTEWATERS |
US4258010A (en) * | 1975-11-19 | 1981-03-24 | Eszakmagyarorszagi Vegyimu_ vek | Solvent extraction apparatus |
JPS5272379A (en) | 1975-12-15 | 1977-06-16 | Toray Ind Inc | Separation of fluid |
US4103685A (en) * | 1976-01-05 | 1978-08-01 | Lupien Paul J | Method and apparatus for extravascular treatment of blood |
DE2710241A1 (en) | 1976-03-11 | 1977-09-22 | Krebs & Co Ag | PROCESS FOR MIXING AND SEPARATING TWO IMMISCABLE LIQUIDS |
JPS5549791Y2 (en) | 1976-04-21 | 1980-11-20 | ||
US4671909A (en) * | 1978-09-21 | 1987-06-09 | Torobin Leonard B | Method for making hollow porous microspheres |
JPS55127104A (en) * | 1979-03-23 | 1980-10-01 | Seikouen Hosono Shinriyoushiyo | Method for continuous extraction of minor component and device therefor |
FR2455743A1 (en) * | 1979-05-02 | 1980-11-28 | Goella Laboratoires | METHOD AND DEVICE FOR DETERMINING SERUM LIPOPROTEINS |
US4234317A (en) | 1979-05-24 | 1980-11-18 | Analytical Products, Inc. | Apparatus and method for fractionation of lipoproteins |
DE2944138A1 (en) * | 1979-11-02 | 1981-06-11 | Technicon Gmbh, 6368 Bad Vilbel | Automatic analysis of separation of deposits from liquids - is by extracting fraction of flowing segmented sample following sedimentation |
DE2949907A1 (en) * | 1979-12-12 | 1981-06-19 | Hoechst Ag, 6230 Frankfurt | FLUOROPOLYMERS WITH SHELL-MODIFIED PARTICLES AND METHOD FOR THE PRODUCTION THEREOF |
FR2475572A1 (en) * | 1980-02-11 | 1981-08-14 | Pasteur Institut | PROCESS FOR OBTAINING LIPID ENVELOPE VIRUS FRAGMENTS, PARTICULARLY ANTIGENS USED AS VACCINES, PRODUCTS OBTAINED AND APPLICATIONS |
EP0036283A3 (en) * | 1980-03-19 | 1982-03-31 | DAVY MCKEE (MINERALS & METALS) LIMITED | Method and apparatus for liquid-liquid extraction |
US4311586A (en) * | 1980-04-22 | 1982-01-19 | Tracor, Inc. | Solvent mixing in HPLC using low pressure solvent metering pumps |
US4350156A (en) * | 1980-05-29 | 1982-09-21 | Japan Foundation For Artificial Organs | Method and apparatus for on-line filtration removal of macromolecules from a physiological fluid |
DE3118072A1 (en) * | 1981-05-07 | 1982-11-25 | Claus-Christian Dr.Rer.Nat. Dr.Med. 6901 Wilhelmsfeld Heuck | Process for separating lipophilic constituents from aqueous colloid solutions for preparative purposes and/or for detecting an analyte in the aqueous phase |
DE3280188D1 (en) | 1981-09-10 | 1990-07-19 | Braun Melsungen Ag | DEVICE FOR SELECTIVE EXTRACORPORAL PRECIPATION OF LOW DENSITY LIPOPROTENS FROM FULL SERUM OR PLASMA. |
US4435289A (en) * | 1981-12-23 | 1984-03-06 | Romicon, Inc. | Series ultrafiltration with pressurized permeate |
JPS58155865A (en) * | 1982-03-12 | 1983-09-16 | 株式会社クラレ | Hollow yarn membrane for treating serum |
DE3213390A1 (en) * | 1982-04-10 | 1983-10-20 | Dieter 3000 Hannover Biela | DEVICE FOR ACCOUNTING FOR LIQUID EXCHANGE IN HAEMOFILTRATIONS |
US4481189A (en) | 1982-04-14 | 1984-11-06 | New York Blood Center Inc. | Process for preparing sterilized plasma and plasma derivatives |
US4591505A (en) * | 1982-04-14 | 1986-05-27 | New York Blood Center, Inc. | Process for inactivating hepatitis B virus |
ATE39321T1 (en) | 1982-08-14 | 1989-01-15 | Utzinger Gustav E | LIQUID SPRAYING DEVICE. |
US4463988A (en) * | 1982-09-07 | 1984-08-07 | Cities Service Co. | Horizontal heated plane process |
SU1204224A1 (en) * | 1982-12-30 | 1986-01-15 | Казанский Ордена Трудового Красного Знамени Химико-Технологический Институт Им.С.М.Кирова | Centrifugal extractor |
US4643718A (en) * | 1983-02-22 | 1987-02-17 | Applied Immunesciences, Inc. | Therapeutic apheresis |
US4540401A (en) * | 1983-02-22 | 1985-09-10 | Applied Immune Sciences, Inc. | In vivo therapeutic apheresis using lipid vesicles |
DE3310263A1 (en) * | 1983-03-22 | 1984-09-27 | Fresenius AG, 6380 Bad Homburg | Process for eliminating lipophilic substances from aqueous solutions and apparatus for carrying out the process |
DE3310727A1 (en) * | 1983-03-24 | 1984-10-04 | B. Braun Melsungen Ag, 3508 Melsungen | METHOD AND DEVICE FOR SELECTIVE, EXTRACORPORAL SEPARATION OF PATHOLOGICAL AND / OR TOXIC BLOOD COMPONENTS |
SU1116396A1 (en) * | 1983-05-23 | 1984-09-30 | 2-Й Московский Ордена Ленина Государственный Медицинский Институт Им.Н.И.Пирогова | Method of removing cholesterol from blood |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US4668398A (en) * | 1983-07-21 | 1987-05-26 | Colgate-Palmolive Company | Continuous extraction apparatus and process |
US4615886A (en) * | 1983-08-31 | 1986-10-07 | The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services | Utilizing a halohydrocarbon containing dissolved water to inactivate a lipid virus |
GB8330094D0 (en) * | 1983-11-11 | 1983-12-21 | Ici Plc | Diphenyl compounds |
JPS60231613A (en) | 1984-04-28 | 1985-11-18 | Terumo Corp | Method for separating humoral component, separation material and separation apparatus therefor |
DE3422494A1 (en) * | 1984-06-16 | 1985-12-19 | B. Braun Melsungen Ag, 3508 Melsungen | METHOD AND DEVICE FOR SPECIFIC ADSORPTION OF HEPARIN |
DE3422407A1 (en) * | 1984-06-16 | 1986-03-06 | B. Braun Melsungen Ag, 3508 Melsungen | USE OF HEPARINE DERIVATIVES FOR SELECTIVE EXTRA-CORPORAL PRECIPITATION OF LOW-DENSITY-LIPOPROTEINS FROM FULL SERUM OR PLASMA |
ATE38846T1 (en) * | 1984-06-27 | 1988-12-15 | Organon Teknika Bv | BINDER FOR LOW DENSITY LIPOPROTEINS. |
FR2571971B1 (en) * | 1984-10-23 | 1988-12-02 | Haas Thierry | DEVICE USING ELASTINE TO LOWER THE CONCENTRATION OF LIPID CONSTITUENTS OF A LIQUID. |
JPS61119271A (en) * | 1984-11-13 | 1986-06-06 | 鐘淵化学工業株式会社 | Blood component treatment circuit and method |
DE3568442D1 (en) * | 1984-12-06 | 1989-04-06 | Kanegafuchi Chemical Ind | A method of preparation of droplets |
US4613501A (en) * | 1984-12-21 | 1986-09-23 | New York Blood Center, Inc. | Inactivation of viruses in labile blood derivatives |
US4970144A (en) | 1984-12-31 | 1990-11-13 | International Genetic Engineering | Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use |
US4677057A (en) * | 1985-03-11 | 1987-06-30 | Scripps Clinic And Research Foundation | Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins |
US4675905A (en) * | 1985-04-12 | 1987-06-23 | Ampex Corporation | Multiple input silent audio switch |
US4645512A (en) * | 1985-05-06 | 1987-02-24 | The Dow Chemical Company | Continuous process for removing water-soluble particles from organic liquids |
US4895558A (en) * | 1985-07-15 | 1990-01-23 | University Of Queensland | Autologous plasma delipidation using a continuous flow system |
CA1259915A (en) * | 1985-10-09 | 1989-09-26 | Sailen S. Mookerjea | Means to reduce plasma cholesterol |
US4832928A (en) * | 1985-10-15 | 1989-05-23 | Thermal Science, Inc. | Method for producing ammonium polyphosphate |
ATE69383T1 (en) * | 1985-11-22 | 1991-11-15 | Schweiz Serum & Impfinst | PROCESS FOR THE PREPARATION OF A RABIES VACCINE AND VACCINE OBTAINED BY SUCH PROCESS. |
US4966709A (en) * | 1985-12-19 | 1990-10-30 | The Cleveland Clinic Foundation | Thermofiltration of plasma |
US5080796A (en) * | 1985-12-19 | 1992-01-14 | The Cleveland Clinic Foundation | Thermofiltration of plasma |
US5203778A (en) * | 1986-02-18 | 1993-04-20 | Boehringer Laboratories | Process and apparatus for removal of insoluble fat from blood of a patient |
US5354262A (en) | 1986-02-18 | 1994-10-11 | Boehringer Laboratories | Apparatus for removal of insoluble fat from blood of a patient |
US4836034A (en) * | 1986-07-15 | 1989-06-06 | Ricoh Company, Ltd. | Force sensing apparatus |
US5126240A (en) * | 1986-09-29 | 1992-06-30 | Curtiss Linda K | Hybridomas and monoclonal paratopic molecules to apolipoprotein a-i |
US4855113A (en) * | 1986-10-27 | 1989-08-08 | Pennwalt Corporation | Apparatus for removing sulfur from organic polysulfides |
US4832034A (en) | 1987-04-09 | 1989-05-23 | Pizziconi Vincent B | Method and apparatus for withdrawing, collecting and biosensing chemical constituents from complex fluids |
US5128318A (en) * | 1987-05-20 | 1992-07-07 | The Rogosin Institute | Reconstituted HDL particles and uses thereof |
WO1988009345A1 (en) * | 1987-05-20 | 1988-12-01 | The Rogosin Institute | Reconstituted hdl particles and uses thereof |
US5256767A (en) * | 1987-06-10 | 1993-10-26 | The Immune Response Corporation | Retroviral antigens |
JPH0829316B2 (en) | 1987-10-16 | 1996-03-27 | 田辺製薬株式会社 | How to remove Pyrogen |
US5055396A (en) * | 1987-11-03 | 1991-10-08 | Scripps Clinic And Research Foundation | Diagnostic methods and systems for quantifying apo ai |
DE3880647T2 (en) * | 1987-11-20 | 1993-11-18 | Kanegafuchi Chemical Ind | Sorbent for serum amyloid proteins. |
US5112956A (en) * | 1987-12-02 | 1992-05-12 | The Nutrasweet Company | Method for extraction of lipids and cholesterol |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
CA1335077C (en) * | 1988-02-08 | 1995-04-04 | Henri Isliker | Process for the manufacture of apolipoproteins from human blood plasma or serum |
DE8802722U1 (en) * | 1988-03-01 | 1988-04-14 | Industrial Technology Research Institute, Hsinchu, Tw | |
US5948441A (en) * | 1988-03-07 | 1999-09-07 | The Liposome Company, Inc. | Method for size separation of particles |
US5152743A (en) * | 1988-08-05 | 1992-10-06 | Healthdyne, Inc. | Apparatus and method for selective separation of blood cholesterol |
US5419759A (en) * | 1988-11-17 | 1995-05-30 | Naficy; Sadeque S. | Apparatus and methods for treatment of HIV infections and AIDS |
US5484396A (en) * | 1988-11-17 | 1996-01-16 | Naficy; Sadeque S. | Method and device for treatment of HIV infections and AIDS |
US5476715A (en) | 1989-10-03 | 1995-12-19 | Fresenius Ag | Particulate adsorbent for the removal of biomacromolecules such as LDL and endotoxins from whole blood in extracorporeal circuits |
US5026479A (en) * | 1990-02-13 | 1991-06-25 | Union Carbide Industrial Gases Technology Corporation | Fluid separation device |
DE4018778A1 (en) * | 1990-06-12 | 1991-12-19 | Braun Melsungen Ag | ADSORPTION MATERIAL FOR THE SELECTIVE REMOVAL OF LDL AND / AND VLDL |
US5116307A (en) * | 1990-07-09 | 1992-05-26 | Collins Harvey T | Method and system for treatment of AIDS |
US5236644A (en) * | 1990-11-27 | 1993-08-17 | W. R. Grace & Co.-Conn. | Process of making membrane for removal of low density lipoprotein-cholesterol from whole blood |
US5418061A (en) * | 1990-11-27 | 1995-05-23 | W. R. Grace & Co.-Conn. | Microporous polysulfone supports suitable for removal of low density lipoprotein-cholesterol |
US5258149A (en) | 1990-11-27 | 1993-11-02 | W. R. Grace & Co.-Conn. | Process of making a membrane for high efficiency removal of low density lipoprotein-cholesterol from whole blood |
US5187010A (en) * | 1990-11-27 | 1993-02-16 | W. R. Grace & Co.-Conn. | Membrane having high affinity for low density lipoprotein-cholesterol from whole blood |
SU1752187A3 (en) * | 1990-12-11 | 1992-07-30 | А.Б.Сигалов | Method for delipidation of lyophilized lipoproteins of high density from human blood serum |
GB9110808D0 (en) | 1991-05-17 | 1991-07-10 | Retroscreen Ltd | Aids vaccine and method for its production |
US5211850A (en) * | 1991-07-26 | 1993-05-18 | Research Medical, Inc. | Plasma filter sorbent system for removal of components from blood |
JP2576744B2 (en) * | 1991-11-05 | 1997-01-29 | 日揮株式会社 | Liquid-liquid contact tower |
US5301694A (en) * | 1991-11-12 | 1994-04-12 | Philip Morris Incorporated | Process for isolating plant extract fractions |
US5391429A (en) * | 1992-01-07 | 1995-02-21 | Diafoil Hoechst Company, Limited | Polyester film |
US5919369A (en) * | 1992-02-06 | 1999-07-06 | Hemocleanse, Inc. | Hemofiltration and plasmafiltration devices and methods |
JP3359921B2 (en) * | 1992-02-24 | 2002-12-24 | クールター インターナショナル コーポレイション | Suspension medium for blood composition and method of using the same |
DE69329108T2 (en) | 1992-03-02 | 2001-03-22 | Bioeng Inc | METHOD FOR INACTIVATING VIRUSES |
JP2744546B2 (en) * | 1992-04-01 | 1998-04-28 | 株式会社栃本天海堂 | Solid extractor |
US5279540A (en) * | 1992-09-24 | 1994-01-18 | Davidson Michael H | Method for reducing the risk of atherosclerosis |
IL104015A0 (en) * | 1992-12-07 | 1993-05-13 | Doina International Ltd P | Method for immunization of mammals against atherosclerosis and pharmaceutical compositions for obtaining said immunization |
US5391143A (en) | 1993-03-12 | 1995-02-21 | Kensey Nash Corporation | Method and system for effecting weight reduction of living beings |
AU680897B2 (en) * | 1993-03-16 | 1997-08-14 | Aventis Pharmaceuticals Inc. | Removal of selected factors from whole blood or its components and prevention and treatment of septic shock symdrome |
US5401466A (en) * | 1993-06-01 | 1995-03-28 | Miles Inc. | Device for the direct measurement of low density lipoprotein cholesterol |
US5753227A (en) * | 1993-07-23 | 1998-05-19 | Strahilevitz; Meir | Extracorporeal affinity adsorption methods for the treatment of atherosclerosis, cancer, degenerative and autoimmune diseases |
PT710126E (en) * | 1993-07-30 | 2004-09-30 | Aruba Internat Pty Ltd | PLASMA DISPIPING SYSTEM |
ATA159993A (en) * | 1993-08-10 | 1995-09-15 | Dieter Dr Falkenhagen | ARRANGEMENT FOR ELIMINATING SUBSTANCES FROM LIQUIDS |
US5652339A (en) * | 1993-12-31 | 1997-07-29 | Rotkreuzstiftung Zentrallaboratorium | Method of producing reconstituted lipoproteins |
EP0766594B1 (en) | 1994-06-22 | 2002-10-23 | Fls Miljo A/S | Mass transfer apparatus |
US5962322A (en) | 1996-11-15 | 1999-10-05 | Massachusetts Institute Of Technology | Methods for modulation of cholesterol transport |
US5637224A (en) * | 1994-09-14 | 1997-06-10 | New Jersey Institute Of Technology | Hollow fiber contained liquid membrane pervaporation for removal of volatile organic compounds from aqueous solutions |
DE4435612A1 (en) | 1994-10-05 | 1996-04-11 | Braun Melsungen Ag | Process for the simultaneous removal of tumor necrosis factor alpha and bacterial lipopolysaccharides from an aqueous liquid |
AUPN030794A0 (en) * | 1994-12-22 | 1995-01-27 | Aruba International Pty Ltd | Discontinuous plasma or serum delipidation |
US5634893A (en) * | 1995-04-24 | 1997-06-03 | Haemonetics Corporation | Autotransfusion apparatus |
JP3595608B2 (en) * | 1995-05-30 | 2004-12-02 | アネルバ株式会社 | Vacuum processing apparatus, method for removing deposited film on inner surface of vacuum vessel in vacuum processing apparatus, and method for uniforming film deposition on inner surface of vacuum vessel in vacuum processing apparatus |
US5719194A (en) * | 1995-08-22 | 1998-02-17 | Ausimont S.P.A. | Prevention and treatment of topical viral infections with perfluoropolyethers or compositions thereof |
US5911698A (en) * | 1995-12-22 | 1999-06-15 | Aruba International Pty. Ltd. | Treatment for cardiovascular and related diseases |
US5858238A (en) * | 1996-03-08 | 1999-01-12 | Baxter Research Medical, Inc. | Salvage of autologous blood via selective membrane/sorption technologies |
US6171373B1 (en) * | 1996-04-23 | 2001-01-09 | Applied Ceramics, Inc. | Adsorptive monolith including activated carbon, method for making said monolith, and method for adsorbing chemical agents from fluid streams |
ATE196148T1 (en) * | 1996-07-10 | 2000-09-15 | American Nat Red Cross | METHOD FOR THE SELECTIVE SEPARATION OF ORGANIC COMPONENTS FROM BIOLOGICAL LIQUIDS |
AU6059898A (en) | 1996-09-05 | 1998-03-26 | Uab Research Foundation, The | Anti-atherosclerotic peptides and a transgenic mouse model of atherosclerosis |
US5707673A (en) * | 1996-10-04 | 1998-01-13 | Prewell Industries, L.L.C. | Process for extracting lipids and organics from animal and plant matter or organics-containing waste streams |
US6008221A (en) | 1996-11-06 | 1999-12-28 | Bristol-Myers Squibb Company | Method for treating Alzheimer's disease with folic acid |
US6605588B1 (en) * | 1996-11-27 | 2003-08-12 | Boston Heart Foundation, Inc. | Low density lipoprotein binding proteins and their use in diagnosing and treating atherosclerosis |
TW318283B (en) * | 1996-12-09 | 1997-10-21 | United Microelectronics Corp | Multi-level read only memory structure and manufacturing method thereof |
AT405939B (en) | 1997-02-24 | 1999-12-27 | Immuno Ag | METHOD FOR INACTIVATING LIPID-ENVIRONED VIRUSES |
US6022333A (en) * | 1997-05-01 | 2000-02-08 | S.L.I.M. Tech, Ltd. | Method and system for removing materials from lymphatic and other fluids |
EP1008383A4 (en) * | 1997-06-03 | 2001-11-21 | Kaneka Corp | Lipoprotein adsorbent and lipoprotein adsorber made with the use of the same |
US6037323A (en) * | 1997-09-29 | 2000-03-14 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6046166A (en) * | 1997-09-29 | 2000-04-04 | Jean-Louis Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US6004925A (en) | 1997-09-29 | 1999-12-21 | J. L. Dasseux | Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
US5980478A (en) | 1997-10-10 | 1999-11-09 | Transvivo, Inc. | Apparatus and method for the treatment of acute and chronic renal disease by continuous passive plasma ultrafiltration |
CN1070380C (en) * | 1997-12-30 | 2001-09-05 | 长春市中心血站 | Application and prodn. method of HDL preparation |
BR9814923A (en) * | 1998-01-28 | 2000-10-17 | Warner Lambert Co | Method for treating alzheimer's disease |
US20020188012A1 (en) * | 1998-01-28 | 2002-12-12 | Bisgaier Charles Larry | Method for treating Alzheimer's disease |
US6080778A (en) * | 1998-03-23 | 2000-06-27 | Children's Medical Center Corporation | Methods for decreasing beta amyloid protein |
US6472421B1 (en) | 1998-11-13 | 2002-10-29 | Nymox Corporation | Methods for treating, preventing, and reducing the risk of the onset of alzheimer's disease using an HMG CoA reductase inhibitor |
US20020055529A1 (en) * | 1998-12-02 | 2002-05-09 | Bisgaier Charles Larry | Method for treating alzheimer's disease |
JP2002533169A (en) * | 1998-12-29 | 2002-10-08 | オキュロジックス コーポレイション | Rheological treatment method and associated apheresis system |
US6214221B1 (en) | 1999-02-22 | 2001-04-10 | Henry B. Kopf | Method and apparatus for purification of biological substances |
US20020107173A1 (en) * | 1999-11-04 | 2002-08-08 | Lawrence Friedhoff | Method of treating amyloid beta precursor disorders |
AUPQ486699A0 (en) | 1999-12-23 | 2000-02-03 | Aruba International Pty Ltd | A method of treating infectious diseases |
US20010028895A1 (en) * | 2000-02-04 | 2001-10-11 | Bisgaier Charles L. | Methods of treating alzheimer's disease |
US6803233B2 (en) | 2000-07-31 | 2004-10-12 | The Regents Of The University Of California | Model for Alzheimer's disease and other neurodegenerative diseases |
AU2002213137A1 (en) * | 2000-10-11 | 2002-04-22 | Esperion Therapeutics, Inc. | Ether compounds and compositions for cholesterol management and related uses |
CA2437480A1 (en) | 2001-02-05 | 2002-08-15 | Andrx Corporation | Method of treating amyloid .beta. precursor disorder |
US6706008B2 (en) * | 2001-03-06 | 2004-03-16 | Baxter International Inc. | Automated system and method for withdrawing compounds from blood |
EP1412045A4 (en) * | 2001-06-25 | 2007-05-02 | Lipid Sciences Inc | Systems and methods using a solvent for the removal of lipids from fluids |
US20040106556A1 (en) * | 2002-08-26 | 2004-06-03 | Yanhong Zhu | Method of treating and preventing alzheimer disease through administration of delipidated protein and lipoprotein particles |
PT2368565E (en) * | 2003-07-03 | 2015-10-19 | Hdl Therapeutics Inc | Enrichment of pre-beta high density lipoproteins |
US7393826B2 (en) * | 2003-07-03 | 2008-07-01 | Lipid Sciences, Inc. | Methods and apparatus for creating particle derivatives of HDL with reduced lipid content |
-
2004
- 2004-03-08 PT PT101853810T patent/PT2368565E/en unknown
- 2004-03-08 JP JP2006518606A patent/JP2007527387A/en active Pending
- 2004-03-08 WO PCT/US2004/006988 patent/WO2005011620A2/en active Application Filing
- 2004-03-08 PT PT04718501T patent/PT1641421T/en unknown
- 2004-03-08 EP EP04718501.2A patent/EP1641421B1/en not_active Expired - Lifetime
- 2004-03-08 ES ES04718501T patent/ES2715496T3/en not_active Expired - Lifetime
- 2004-03-08 ES ES10185381.0T patent/ES2547547T3/en not_active Expired - Lifetime
- 2004-03-08 AU AU2004260632A patent/AU2004260632A1/en not_active Abandoned
- 2004-03-08 DK DK10185381.0T patent/DK2368565T3/en active
- 2004-03-08 US US10/796,691 patent/US7375191B2/en not_active Expired - Lifetime
- 2004-03-08 DK DK04718501.2T patent/DK1641421T3/en active
- 2004-03-08 EP EP10185381.0A patent/EP2368565B1/en not_active Expired - Lifetime
- 2004-03-08 CA CA002531227A patent/CA2531227A1/en not_active Abandoned
- 2004-11-23 US US10/996,570 patent/US7361739B2/en not_active Expired - Lifetime
-
2008
- 2008-03-05 US US12/042,924 patent/US20080214438A1/en not_active Abandoned
- 2008-03-24 US US12/054,162 patent/US8048015B2/en active Active
- 2008-03-24 US US12/054,088 patent/US20080230465A1/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
CLAY ET AL: "Formation of apolipoprotein high density lipoprotein particles form lipid-free apolipoprotiens A-I and A-II.", BIOCHEM J., vol. 337, September 2000 (2000-09-01), pages 455 - 451, XP002996450 * |
DURBIN ET AL: "Lipid-free apolipoproteins A-I and A-II promote remodeling of reconstituted high density lipoproteins and alter their reactivity with lecithin:cholesterol acyltransferase.", J LIPID RES., vol. 40, September 1999 (1999-09-01), pages 2293 - 2302, XP002996451 * |
See also references of EP1641421A4 * |
TRICERRI ET AL: "Interaction of apolipoprotein A-I in three different conformations with palmitoyl oleoyl phosphatidylcholine vesicles.", J LIPID RES., vol. 43, November 2002 (2002-11-01), pages 187 - 197, XP002996452 * |
Also Published As
Publication number | Publication date |
---|---|
PT1641421T (en) | 2019-03-27 |
CA2531227A1 (en) | 2005-02-10 |
ES2547547T3 (en) | 2015-10-07 |
EP1641421A2 (en) | 2006-04-05 |
DK1641421T3 (en) | 2019-03-11 |
US20050090444A1 (en) | 2005-04-28 |
US8048015B2 (en) | 2011-11-01 |
US7375191B2 (en) | 2008-05-20 |
US20080230465A1 (en) | 2008-09-25 |
WO2005011620A2 (en) | 2005-02-10 |
US20080214438A1 (en) | 2008-09-04 |
EP1641421A4 (en) | 2006-10-18 |
AU2004260632A1 (en) | 2005-02-10 |
US7361739B2 (en) | 2008-04-22 |
US20080234621A1 (en) | 2008-09-25 |
DK2368565T3 (en) | 2015-09-28 |
EP1641421B1 (en) | 2018-12-26 |
EP2368565B1 (en) | 2015-06-24 |
JP2007527387A (en) | 2007-09-27 |
ES2715496T3 (en) | 2019-06-04 |
PT2368565E (en) | 2015-10-19 |
EP2368565A1 (en) | 2011-09-28 |
US20050004004A1 (en) | 2005-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2005011620A3 (en) | Methods and apparatus for creating particle derivatives of hdl with reduced lipid content | |
Gotto Jr et al. | Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial Data Issues from the interdisciplinary council on reducing the risk for coronary heart disease, ninth council meeting | |
Gierman et al. | Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE* 3Leiden. CETP mice—a translational model for atherosclerosis | |
Gotto Jr | Review of primary and secondary prevention trials with lovastatin, pravastatin, and simvastatin | |
Fuji et al. | Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS JV trial | |
Isaacsohn et al. | Effects of lovastatin therapy on plasminogen activator inhibitor-1 antigen levels | |
Tamura et al. | Nicorandil, a Katp channel opener, alleviates chronic renal injury by targeting podocytes and macrophages | |
WO2002058696A3 (en) | The use of substituted azetidinone compounds for the treatment of sitosterolemia | |
MXPA03002964A (en) | Compositions and methods for lowering plasma lipoprotein(a) and risk factors of cardiovascular diseases. | |
Borberg | 26 years of LDL–apheresis: a review of experience | |
Zinellu et al. | Increased low-density lipoprotein S-homocysteinylation in chronic kidney disease | |
de Man et al. | Effects of protein and calorie restriction on the metabolism and toxicity profile of irinotecan in cancer patients | |
Al-Quobaili et al. | Serum levels of lipids and lipoproteins in Syrian patients with beta-thalassemia major | |
Naoum et al. | Aortic eNOS expression and phosphorylation in Apo-E knockout mice: differing effects of rapamycin and simvastatin | |
Esmon | What did we learn from new oral anticoagulant treatment? | |
Rideout et al. | Combination drug–diet therapies for dyslipidemia | |
Schettler et al. | How to optimize lipoprotein apheresis treatment–a second look | |
Fitzpatrick et al. | Prolonged low-volume resuscitation with HBOC-201 in a large-animal survival model of controlled hemorrhage | |
RU2009116632A (en) | KETOCONAZOLE ENANTIOMER IN PEOPLE | |
McKenney | Combination therapy for elevated low-density lipoprotein cholesterol: the key to coronary artery disease risk reduction | |
Ballantyne | Rationale for targeting multiple lipid pathways for optimal cardiovascular risk reduction | |
Gälman et al. | Pharmacological interference with intestinal bile acid transport reduces plasma cholesterol in LDL receptor/apoE deficiency | |
Oztuna et al. | The effect of pentoxifylline in treatment of skin degloving injuries: an experimental study | |
McKoy et al. | Investigation of the effects of a sapogenin-rich preparation from a Jamaican yam (Dioscorea sp.) on blood cholesterol levels in rats | |
Aikpokpo et al. | Management of the Failing Kidney Transplant: Challenges and Solutions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004718501 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006518606 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004260632 Country of ref document: AU |
|
ENP | Entry into the national phase |
Ref document number: 2531227 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 2004260632 Country of ref document: AU Date of ref document: 20040308 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2004260632 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 2004718501 Country of ref document: EP |